Related Experiment Video

Updated: Aug 30, 2026

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

Treatment of hepatitis C virus in the coinfected patient

Christine Brennan1

  • 1Department of Public Health & Preventive Medicine-HIV Outpatient Program, Louisiana State University Health Sciences Center, USA.

The Journal of the Association of Nurses in AIDS Care : JANAC
|October 24, 2003
PubMed

Insights

Hepatitis C virus (HCV) impacts HIV disease progression and treatment in coinfected individuals. This review addresses monitoring, treatment, and side effects of HCV in the coinfected population.

Area of Science:

  • Hepatology
  • Infectious Diseases
  • HIV Medicine

Background:

  • Hepatitis C virus (HCV) infection significantly impacts the human immunodeficiency virus (HIV) infected population.
  • HCV influences the course and treatment of HIV disease in coinfected individuals.

Purpose of the Study:

  • To review current data on monitoring and treating HCV in coinfected individuals.
  • To address challenges and side effects associated with HCV treatment in this population.

Main Methods:

  • Literature review of available data on HCV treatment in coinfected patients.
  • Analysis of monitoring strategies before and during HCV therapy.
  • Examination of side effect management for HCV treatment.

Main Results:

  • Significant data gaps exist regarding optimal HCV monitoring and treatment in coinfected individuals.
  • HCV treatment in coinfected patients requires careful consideration of potential side effects.
  • HIV nurses play a crucial role in supporting, educating, and advocating for coinfected patients.

Conclusions:

  • Further research is needed to establish definitive guidelines for HCV management in coinfected individuals.
  • Comprehensive care, including monitoring and side effect management, is essential.
  • Healthcare providers, particularly HIV nurses, must enhance their knowledge to effectively manage coinfected patients.

More Related Videos

A Protocol for Analyzing Hepatitis C Virus Replication13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...